TIMOTHY J. MCDONNELL, M.D., PHD
Medical Practice at Holcombe Blvd, Houston, TX
License number
Texas H9683
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about TIMOTHY J. MCDONNELL at radaris.comName
Address
Phone
408 Fort Thomas Pl, Round Rock, TX 78664
3401 W Business 83 #257, Harlingen, TX 78552
271 Longmont Ln, Austin, TX 78737
14103 Manderly Dr, Houston, TX 77077
190 Mcduff Ct, Harlingen, TX 78552
Professional information
Dr. Timothy J Mcdonnell, Houston TX - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
1515 Holcombe Blvd SUITE 89, Houston 77030
(713) 792-6161 (Phone), (713) 792-6161 (Fax)
Houston Office
1515 Holcombe Blvd SUITE 10, Houston 77030
(877) 632-6789 (Phone)
(713) 792-6161 (Phone), (713) 792-6161 (Fax)
Houston Office
1515 Holcombe Blvd SUITE 10, Houston 77030
(877) 632-6789 (Phone)
Certifications:
Anatomic Pathology, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1515 Holcombe Blvd SUITE 89, Houston 77030
Houston Office
1515 Holcombe Blvd SUITE 10, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Houston Office
1515 Holcombe Blvd SUITE 10, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Education:
Medical School
Washington Center / School of Medicine
Graduated: 1986
Washington Center / School of Medicine
Graduated: 1986
Timothy J McDonnell, Houston TX
Specialties:
Pathologist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
Washington University, School of Medicine - Doctor of Medicine*
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology)*
Induction Of Apoptic Or Cytotoxic Gene Expression By Adenoviral Mediated Gene Codelivery
US Patent:
6899870, May 31, 2005
Filed:
Mar 11, 1999
Appl. No.:
09/266465
Inventors:
Timothy J. McDonnell - Houston TX, US
Stephen G. Swisher - Fresno TX, US
Bingliang Fang - Houston TX, US
Elizabeth M. Bruckheimer - Houston TX, US
Mona G. Sarkiss - Houston TX, US
Lin Ji - SugarLand TX, US
Jack A. Roth - Houston TX, US
Stephen G. Swisher - Fresno TX, US
Bingliang Fang - Houston TX, US
Elizabeth M. Bruckheimer - Houston TX, US
Mona G. Sarkiss - Houston TX, US
Lin Ji - SugarLand TX, US
Jack A. Roth - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
A61K048/00, C12N015/861, C12N015/63, C07H021/04
US Classification:
424 932, 424 931, 424 936, 4353201, 435 691, 435455, 435456, 435457, 536 231, 536 232, 536 234, 536 235, 536 241
Abstract:
The present invention generally relates to viral vectors and their use as expression vectors for transforming human cells, both in vitro and in vivo. More particularly, the present invention relates to adenoviral vectors containing propapoptotic genes and their use in cancer therapy.
Inhibition Of Bcl-2 Protein Expression By Liposomal Antisense Oligodeoxynucleotides
US Patent:
7285288, Oct 23, 2007
Filed:
Oct 3, 1997
Appl. No.:
09/381747
Inventors:
Mar Tormo - Valencia, ES
Ana M Tari - Houston TX, US
Timothy J McDonnell - Houston TX, US
Ana M Tari - Houston TX, US
Timothy J McDonnell - Houston TX, US
Assignee:
Board of Regents, the University of Texas System - Austin TX
International Classification:
C12Q 1/68, C07H 21/02, C07H 21/04, A01K 9/127
US Classification:
424450, 435 911, 536 231, 536 243, 536 245, 514 44
Abstract:
The present invention provides novel compositions and methods for use in the treatment of Bcl-2-associated diseases like cancer, specifically, in the treatment of follicular lymphoma (FL). The compositions contain antisense oligonucleotides that hybridize to Bcl-2 nucleic acids, the gene products of which are known to interact with the tumorigenic protein Bcl-2. Used alone, or in conjunction with other antisense oligonucleotides, these compositions inhibit the proliferation of FL cancer cells.
Induction Of Apoptic Or Cytotoxic Gene Expression By Adenoviral Mediated Gene Codelivery
US Patent:
2006000, Jan 5, 2006
Filed:
May 31, 2005
Appl. No.:
11/141678
Inventors:
Timothy McDonnell - Houston TX, US
Stephen Swisher - Fresno TX, US
Bingliang Fang - Houston TX, US
Elizabeth Bruckheimer - Houston TX, US
Mona Sarkiss - Houston TX, US
Lin Ji - Sugar Land TX, US
Jack Roth - Houston TX, US
Stephen Swisher - Fresno TX, US
Bingliang Fang - Houston TX, US
Elizabeth Bruckheimer - Houston TX, US
Mona Sarkiss - Houston TX, US
Lin Ji - Sugar Land TX, US
Jack Roth - Houston TX, US
International Classification:
A61K 48/00, A61K 38/16, A61K 31/704, A61K 31/7048
US Classification:
424093200, 514008000, 514027000, 514034000, 514044000, 514109000, 514410000, 514283000, 514269000
Abstract:
The present invention generally relates to viral vectors and their use as expression vectors for transforming human cells, both in vitro and in vivo. More particularly, the present invention relates to adenoviral vectors containing propapoptotic genes and their use in cancer therapy.